Journal of Medicinal Chemistry
Brief Article
14, 147−150. (b) Sun, L.; Vasilevich, N. I.; Fuselier, J. A.; Hocart, S. J.;
Coy, D. H. Examination of the 1,4-disubstituted azetidinone ring
system as a template for combretastatin A-4 conformationally
restricted analogue design. Bioorg. Med. Chem. Lett. 2004, 14, 2041−
2046.
(10) Nivsarkar, M.; Thavaselvam, D.; Prasanna, S.; Sharma, M.;
Kaushik, M. P. Design, synthesis and biological evaluation of novel
bicyclic β-lactams as potential antimalarials. Bioorg. Med. Chem. Lett.
2005, 15, 1371−1373.
(11) Kvaerno, L.; Werder, M.; Houser, H.; Carreira, E. M. Synthesis
and in vitro evaluation of inhibitors of intestinal cholesterol
absorption. J. Med. Chem. 2005, 48, 6035−6053.
novel antimalarial pharmacophores. Eur. J. Med. Chem. 2011, 46, 579−
587.
́ ́
(21) (a) Boto, A.; Hernandez, D.; Hernandez, R. One-pot synthesis
of azanucleosides from proline derivativesstereoselectivity in
sequential processes. Eur. J. Org. Chem. 2010, 3847−3857.
(b) Wang, J.-L.; Xu, J.-M.; Wu, Q.; Lv, D.-S.; Lin, X.-F. Promiscuous
enzyme-catalyzed regioselective Michael addition of purine derivatives
to α,β-unsaturated carbonyl compounds in organic solvent. Tetrahe-
dron 2009, 65, 2531−2536. (c) Baraldi, P. G.; Broceta, A. U.; Pineda
de las Infantas, M. J.; Mochun, J. J. D.; Espinosa, A.; Romagnoli, R. An
efficient one-pot synthesis of 6-alkoxy-8,9-dialkylpurines via reaction of
5-amino-4-chloro-6-alkylaminopyrimidines with N,N-dimethylalkanea-
mides and alkoxide ions. Tetrahedron 2002, 58, 7607−7611.
(12) Selected reviews: (a) Alcaide, B.; Almendros, P.; Aragoncillo, C.
β-Lactams: versatile building blocks for the stereoselective synthesis of
non-β-lactam products. Chem. Rev. 2007, 107, 4437−4492. (b) Pal-
omo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Asymmetric
synthesis of β-lactams through the Staudinger reaction and their use as
building blocks of natural and nonnatural products. Curr. Med. Chem.
2004, 11, 1837−1872. (c) D’hooghe, M.; Dekeukeleire, S.; Leemans,
E.; De Kimpe, N. Use of functionalized β-lactams as building blocks in
heterocyclic chemistry. Pure Appl. Chem. 2010, 82, 1749−1759.
(22) Chrysant, S. G.; Chrysant, G. S.; Dimas, B. Current and future
status of beta-blockers in the treatment of hypertension. Clin. Cardiol.
2008, 31, 249−252.
(23) (a) Bair, K. W.; Tuttle, R. L.; Knick, V. C.; Cory, M.; McKee, D.
D. 1-Pyrenylmethyl)amino alcohols, a new class of antitumor DNA
intercalators. Discovery and initial amine side-chain structure activity
studies. J. Med. Chem. 1990, 33, 2385−2393. (b) Bair, K. W.; Andrews,
C. W.; Tuttle, R. L.; Knick, V. C.; Cory, M.; McKee, D. D. 2-
[(Arylmethyl)amino]-2-methyl-1,3-propanediol DNA intercalators. An
examination of the effects of aromatic ring variation on antitumor
activity and DNA-binding. J. Med. Chem. 1991, 34, 1983−1990.
(24) Feder, H. M.; Osier, C.; Maderazo, E. G. Chloramphenicol: a
review of its use in clinical-practice. Rev. Infect. Dis. 1981, 3, 479−491.
(25) (a) Speeter, M. E.; Maroney, W. H. The action of lithium
aluminum hydride on a β-lactam. J. Am. Chem. Soc. 1954, 76, 5810−
5811. (b) Sammes, P. G.; Smith, S. On the synthesis of azetidines from
3-hydroxypropylamines. J. Chem. Soc., Chem. Commun. 1983, 682−
684. (c) D’hooghe, M.; Dekeukeleire, S.; Mollet, K.; Lategan, C.;
Smith, P. J.; Chibale, K.; De Kimpe, N. Synthesis of novel 2-alkoxy-3-
amino-3-arylpropan-1-ols and 5-alkoxy-4-aryl-1,3-oxazinanes with
antimalarial activity. J. Med. Chem. 2009, 52, 4058−4062.
(d) D’hooghe, M.; Mollet, K.; Dekeukeleire, S.; De Kimpe, N.
Stereoselective synthesis of trans- and cis-2-aryl-3-(hydroxymethyl)-
aziridines through transformation of 4-aryl-3-chloro-β-lactams and
study of their ring opening. Org. Biomol. Chem. 2010, 8, 607−615.
(e) Alcaide, B.; Almendros, P.; Cabrero, G.; Ruiz, M. P. Stereo-
controlled access to orthogonally protected anti,anti-4-aminopiper-
idine-3,5-diols through chemoselective reduction of enantiopure β-
lactam cyanohydrins. J. Org. Chem. 2007, 72, 7980−7991.
(13) Domling, A.; Starnecker, M.; Ugi, I. The β-lactam-nucleoside
̈
chimera. Angew. Chem., Int. Ed. 1995, 34, 2238−2239.
(14) Basak, A.; Pal, R. Synthesis of β-lactam nucleoside chimera via
Kinugasa reaction and evaluation of their antibacterial activity. Bioorg.
Med. Chem. Lett. 2005, 15, 2015−2018.
(15) (a) D’hooghe, M.; Dekeukeleire, S.; De Kimpe, N. Reactivity of
N-(ω-haloalkyl)-β-lactams with regard to lithium aluminium hydride:
novel synthesis of 1-(1-aryl-3-hydroxypropyl)aziridines and 3-aryl-3-
(N-propylamino)propan-1-ols. Org. Biomol. Chem. 2008, 6, 1190−
1196. (b) Van Brabandt, W.; Vanwalleghem, M.; D’hooghe, M.; De
Kimpe, N. Asymmetric synthesis of 1-(2- and 3-haloalkyl)azetidin-2-
ones as precursors for novel piperazine, morpholine, and 1,4-diazepane
annulated β-lactams. J. Org. Chem. 2006, 71, 7083−7086.
(c) D’hooghe, M.; Dejaegher, Y.; De Kimpe, N. Synthesis of trans-4-
aryl-3-(3-chloropropyl)azetidin-2-ones and their transformation into
trans- and cis-2-arylpiperidine-3-carboxylates. Tetrahedron 2008, 64,
4575−4584.
(16) (a) Barrow, K. D.; Spotswood, T. M. Stereochemistry and
proton magnetic resonance spectra of β-lactams. Tetrahedron Lett.
1965, 6, 3325−3335. (b) Decazes, J.; Luche, J. L.; Kagan, H. B.
Cycloaddition of ketenes to Schiff’s bases. III. NMR configuration
determination of 1,3,4 triphenyl-3-alkyl-2-azetidinones. Tetrahedron
Lett. 1970, 11, 3361.
(17) (a) Xu, J. Stereoselectivity in the synthesis of 2-azetidinones
from ketenes and imines via the Staudinger reaction. ARKIVOC 2009,
ix, 21−44. (b) Jiao, L.; Liang, Y.; Xu, J. Origin of the relative
stereoselectivity of the β-lactam formation in the Staudinger reaction.
J. Am. Chem. Soc. 2006, 128, 6060−6069.
(18) Legraverend, M. Recent advances in the synthesis of purine
derivatives and their precursors. Tetrahedron 2008, 64, 8585−8603.
(19) (a) Zhong, M.; Robins, M. J. Regiospecific N9 alkylation of 6-
(heteroaryl)purines: shielding of N7 by a proximal heteroaryl C-H1. J.
Org. Chem. 2006, 71, 8901−8906. (b) Lu, W.; Sengupta, S.; Petersen,
J. L.; Akhmedov, N. G.; Shi, X. Mitsunobu coupling of nucleobases
and alcohols: an efficient, practical synthesis for novel nonsugar carbon
nucleosides. J. Org. Chem. 2007, 72, 5012−5015. (c) Zhong, M.;
Nowak, I.; Cannon, J. F.; Robins, M. J. Structure and synthesis of 6-
(substituted-imidazol-1-yl)purines: versatile substrates for regiospecific
alkylation and glycosylation at N9. J. Org. Chem. 2006, 71, 4216−4221.
(d) Alarcon, K.; Martelli, A.; Demeunynck, M.; Lhomme, J. 2-Amino-
6-(1,2,4-triazol-4-yl)-purine: a useful intermediate in the synthesis of
9-alkylguanines. Tetrahedron Lett. 2000, 41, 7211. (e) Geen, G. R.;
Grinter, T. J.; Kincey, P. M.; Jarvest, R. L. The effect of the C-6
substituent on the regioselectivity of N-alkylation of 2-aminopurines.
Tetrahedron 1990, 46, 6903−6914.
(20) D’hooghe, M.; Kenis, S.; Vervisch, K.; Lategan, C.; Smith, P. J.;
Chibale, K.; De Kimpe, N. Synthesis of 2-(aminomethyl)aziridines and
their microwave-assisted ring opening to 1,2,3-triaminopropanes as
5641
dx.doi.org/10.1021/jm300383k | J. Med. Chem. 2012, 55, 5637−5641